Concurrent administration of liposomal doxorubicin improves the survival of patients with invasive bladder cancer undergoing hypofractionated accelerated radiotherapy (HypoARC).
about
Concurrent administration of liposomal doxorubicin improves the survival of patients with invasive bladder cancer undergoing hypofractionated accelerated radiotherapy (HypoARC).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Concurrent administration of l ...... erated radiotherapy (HypoARC).
@en
Concurrent administration of l ...... nated accelerated radiotherapy
@nl
type
label
Concurrent administration of l ...... erated radiotherapy (HypoARC).
@en
Concurrent administration of l ...... nated accelerated radiotherapy
@nl
prefLabel
Concurrent administration of l ...... erated radiotherapy (HypoARC).
@en
Concurrent administration of l ...... nated accelerated radiotherapy
@nl
P2093
P2860
P1433
P1476
Concurrent administration of l ...... erated radiotherapy (HypoARC).
@en
P2093
Alexandra Giatromanolaki
Christos Kalaitzis
George Kyrgias
Kiriaki Pistevou
Marianthi Panteliadou
Michael I Koukourakis
Pelagia Tsoutsou
Stavros Touloupidis
P2860
P2888
P304
P356
10.1007/S12032-010-9544-X
P577
2010-04-28T00:00:00Z
P6179
1033399802